APA (7th ed.) Citation

Rauch, G., & Kieser, M. (2018). Time-to-first-event versus recurrent-event analysis: Points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints. Clinical research in cardiology, 107(5), . https://doi.org/10.1007/s00392-018-1205-7

Chicago Style (17th ed.) Citation

Rauch, Geraldine, and Meinhard Kieser. "Time-to-first-event Versus Recurrent-event Analysis: Points to Consider for Selecting a Meaningful Analysis Strategy in Clinical Trials with Composite Endpoints." Clinical Research in Cardiology 107, no. 5 (2018). https://doi.org/10.1007/s00392-018-1205-7.

MLA (9th ed.) Citation

Rauch, Geraldine, and Meinhard Kieser. "Time-to-first-event Versus Recurrent-event Analysis: Points to Consider for Selecting a Meaningful Analysis Strategy in Clinical Trials with Composite Endpoints." Clinical Research in Cardiology, vol. 107, no. 5, 2018, https://doi.org/10.1007/s00392-018-1205-7.